Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib Monotherapy in Heavily Pretreated HRD/gBRCA-Positive Ovarian Cancer (China, Phase II)
CTR20200750Phase 2Completed
- Sponsor
- Zai Lab
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Zai Lab. Started May 2020; status: completed.
02
Drugs
niraparib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on CTR20200750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200750.